BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Bone morphogenetic protein 9 (BMP9; GDF2); bone morphogenetic protein receptor type II (BMPRII)

July 9, 2015 7:00 AM UTC

Cell culture and mouse studies suggest BMP9 could help treat pulmonary arterial hypertension (PAH). Mutations in BMPRII have been associated with PAH pathogenesis. In assays in endothelial cells from ...